Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7229613 | DAIICHI SANKYO | Method for lowering serum glucose |
Apr, 2022
(1 year, 5 months ago) | |
US7229613 (Pediatric) | DAIICHI SANKYO | Method for lowering serum glucose |
Oct, 2022
(11 months ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M (M) | Oct 20, 2024 |
Drugs and Companies using COLESEVELAM HYDROCHLORIDE ingredient
Market Authorisation Date: 02 October, 2009
Treatment: Treatment of type 2 diabetes mellitus
Dosage: FOR SUSPENSION;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic